Trevi Therapeutics Announces the Initiation of its Phase 2a

Trevi Therapeutics Announces the Initiation of its Phase 2a RIVER Clinical Trial of Haduvio™ for Refractory Chronic Cough

Trevi Therapeutics Announces the Initiation of its Phase 2a RIVER Clinical Trial of Haduvio™ for Refractory Chronic Cough

kptv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kptv.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

United States , Katie Mcmanus , Rosalia Scampoli , Prnewswire Trevi Therapeutics Inc , Us Drug Enforcement Agency , Twitter , Nasdaq , Linkedin , Exchange Commission , Trevi Therapeutics Inc , Jennifer Good , Trial Design , Refractory Chronic Cough Improvement Via Nal , Refractory Chronic Cough , Trevi Therapeutics , Private Securities Litigation Reform Act ,